The three lab stewardship utilization rights: Underutilization in focus

Laboratory testing is critically important to a person’s healthcare journey. In fact, lab test results inform 70% of medical decisions despite only accounting for less than 3% of healthcare spending.However, with the great power of the lab, comes great fiscal responsibility. In this article, Todd Berman, payor solutions director of stewardship strategies at Labcorp, outlines the three lab stewardship rights, with an in-depth look at underutilization.

Labcorp Expands Molecular Bioanalytical Laboratory in Greenfield, Indiana

BURLINGTON, N.C., Sept. 18, 2024 – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its molecular bioanalytical laboratory in Greenfield, Indiana. 

Blue Cross and Blue Shield of Alabama Announces Relationship with Labcorp to Provide Members Best Overall Value for Outpatient Lab-Related Services

BIRMINGHAM, AL, Sept. 17, 2024 – Blue Cross and Blue Shield of Alabama’s mission is to provide our members access to high quality, affordable care, delivered by the most cost-effective healthcare providers.

Cinven to sell minority stake in SYNLAB to strategic investor Labcorp

International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic investor Labcorp. Labcorp is a global leader of innovative and comprehensive laboratory services

LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034

BURLINGTON, N.C. , Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) ( Labcorp ) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has priced its offering of $2,000,000,000 in senior notes (the Offering).

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Enhances Labcorp's laboratory services network and expands access to its clinical services  BURLINGTON, N.C. and MIAMI , Sept. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc.

Labcorp to Acquire Select Outreach Services from Ballad Health

Transfer of outreach services brings enhanced global resources to region, including expanded access to advanced testing, innovative digital tools for improved patient experience and achieves Ballad Health’s goal of continuing to lower the cost of health care JOHNSON CITY, Tenn.

Labcorp to Acquire Select Outreach Services From Ballad Health

Johnson City, Tenn. and BURLINGTON, N.C. , Sept. 9, 2024 --  Ballad Health announced today it has reached agreement on a strategic collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, to provide outreach laboratory services across the Appalachian Highlands region.

Labcorp to Speak at the Baird 2024 Global Healthcare Conference

BURLINGTON, N.C. , Sept. 3, 2024 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the Baird 2024 Global Healthcare Conference on Tuesday,

Leveraging lab data to combat diabetes and chronic kidney disease

Social determinants of health impact an estimated 80%-90% of patient outcomes. Learn how you can leverage lab data to enhance population health, see hot spots that need attention and target them through preventive and gaps in care programs